Linda Wagner-Weiner to Immunosuppressive Agents
This is a "connection" page, showing publications Linda Wagner-Weiner has written about Immunosuppressive Agents.
Connection Strength
0.565
-
Comparing Rituximab and Cyclophosphamide in Induction Therapy for Childhood-Onset Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis: An ARChiVe Registry Cohort Study. Arthritis Care Res (Hoboken). 2025 Apr; 77(4):504-512.
Score: 0.155
-
Pediatric anti-NMDA receptor encephalitis with catatonia: treatment with electroconvulsive therapy. Pediatr Rheumatol Online J. 2019 Feb 18; 17(1):8.
Score: 0.104
-
Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatr Rheumatol Online J. 2018 Oct 22; 16(1):65.
Score: 0.101
-
Systemic Juvenile Idiopathic Arthritis Complicated by Macrophage Activation Syndrome. Pediatr Ann. 2015 Jun; 44(6):e142-7.
Score: 0.080
-
Consensus treatment plans for induction therapy of newly diagnosed proliferative lupus nephritis in juvenile systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 Mar; 64(3):375-83.
Score: 0.064
-
Evaluating Renal Disease in Pediatric-Onset Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Disease Course, Outcomes, and Predictors of Outcome. Arthritis Rheumatol. 2025 May; 77(5):606-614.
Score: 0.039
-
Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study. Arthritis Rheumatol. 2016 10; 68(10):2514-26.
Score: 0.022